{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:50:19Z","timestamp":1790185819093,"version":"4.1.0"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gambl Stud"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1023\/a:1021227214142","type":"journal-article","created":{"date-parts":[[2003,3,21]],"date-time":"2003-03-21T00:56:49Z","timestamp":1048208209000},"page":"85-109","source":"Crossref","is-referenced-by-count":69,"title":["Advances in the Pharmacological Treatment of Pathological Gambling"],"prefix":"10.1007","volume":"19","author":[{"given":"Jon E.","family":"Grant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suck","family":"Won Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc N.","family":"Potenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"454074_CR1","first-page":"780","volume":"151","author":"M.J. Albanese","year":"1994","unstructured":"Albanese, M.J., Khantzian, E.J., Murphy, S.L., & Green, A.I. (1994). Decreased substance use in chronically psychotic patients treated with clozapine. American Journal of Psychiatry, 151, 780\u2013781. [Letter].","journal-title":"American Journal of Psychiatry"},{"key":"454074_CR2","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association Committee on NomenclatureStatistics","year":"1980","unstructured":"American Psychiatric Association Committee on Nomenclature and Statistics. (1980). Diagnostic and statistical manual of mental disorders (3rd Ed.). Washington, D.C.: American Psychiatric Association.","edition":"3rd Ed."},{"key":"454074_CR3","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association Committee on NomenclatureStatistics","year":"1987","unstructured":"American Psychiatric Association Committee on Nomenclature and Statistics. (1987). Diagnostic and statistical manual of mental disorders (3rd Ed.-Revised). Washington, D.C.: American Psychiatric Association.","edition":"3rd Ed.-Revised"},{"key":"454074_CR4","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association Committee on NomenclatureStatistics","year":"2000","unstructured":"American Psychiatric Association Committee on Nomenclature and Statistics. (2000). Diagnostic and statistical manual of mental disorders (4th Ed.-Text Revision). Washington, D.C.: American Psychiatric Association.","edition":"4th Ed.-Text Re"},{"key":"454074_CR5","first-page":"644","volume":"93","author":"R.P. Barrett","year":"1989","unstructured":"Barrett, R.P., Feinstein, C., & Hole, W.T. (1989). Effects of naloxone and naltrexone on self-injury: a double-blind, placebo-controlled analysis. American Journal of Mental Retardation, 93, 644\u2013651.","journal-title":"American Journal of Mental Retardation"},{"key":"454074_CR6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/scnp.2001.22921","volume":"6","author":"C. Blanco","year":"2001","unstructured":"Blanco, C., Moreyra, P., Nunes, E.V., S\u00e1iz-Ruiz, J., & Ib\u00e1nez, A. (2001). Pathological gambling: addiction or compulsion? Seminars in Clinical Neuropsychiatry, 6, 167\u2013176.","journal-title":"Seminars in Clinical Neuropsychiatry"},{"key":"454074_CR7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1176\/ajp.153.1.119","volume":"153","author":"C. Blanco","year":"1996","unstructured":"Blanco, C., Orensanz-Munoz, L., Blanco-Jerez, C., & Saiz-Ruiz, J. (1996). Pathological gambling and platelet MAO activity: a psychobiological study. American Journal of Psychiatry, 153, 119\u2013121.","journal-title":"American Journal of Psychiatry"},{"key":"454074_CR8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/10401230209147393","volume":"14","author":"C. Blanco","year":"2002","unstructured":"Blanco, C., Petkova, E., Ibanez, A., & S\u00e1iz-Ruiz, J. (2002). A pilot placebo-controlled study of fluvoxamine for pathological gambling. Annals of Clinical Psychiatry, 14, 9\u201315.","journal-title":"Annals of Clinical Psychiatry"},{"key":"454074_CR9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0091-3057(79)90137-0","volume":"11","author":"C.L. Broekkamp","year":"1979","unstructured":"Broekkamp, C.L. & Phillips, A.G. (1979). Facilitation of self-stimulation behavior following intracerebral microinjections of opioids into the ventral tegmental area. Pharmacology Biochemistry and Behavior, 11, 289\u2013295.","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"454074_CR10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1176\/ajp.151.3.385","volume":"151","author":"P. Buckley","year":"1994","unstructured":"Buckley, P., Thompson, P., Way, L., & Meltzer, H.Y. (1994). Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy. American Journal of Psychiatry, 151, 385\u2013389.","journal-title":"American Journal of Psychiatry"},{"key":"454074_CR11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1600-0447.1994.tb01619.x","volume":"90","author":"J.L. Carrasco","year":"1994","unstructured":"Carrasco, J.L., Saiz-Ruiz, J., Hollander, E., Cesar, J., & Lopez-Ibor Jr., J.J. (1994). Low platelet monoamine oxidase activity in pathological gambling. Acta Psychiatrica Scandinavia, 90, 427\u20133","journal-title":"Acta Psychiatrica Scandinavia"},{"key":"454074_CR12","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/archpsyc.58.8.755","volume":"58","author":"K.M. Carroll","year":"2001","unstructured":"Carroll, K.M., Ball, S.A., Nich, C., O'Connor, P.G., Eagan, D.A., Frankforter, T.L., Triffleman, E.G., Shi, J., & Rounsaville, B.J. (2001). Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence. Archives of General Psychiatry, 58, 755\u2013761.","journal-title":"Archives of General Psychiatry"},{"key":"454074_CR13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0006-3223(01)01134-9","volume":"50","author":"R.A. Chambers","year":"2001","unstructured":"Chambers, R.A., Krystal, J. H., & Self, D.W. (2001). A neurobiological basis for substance abuse comorbidity in schizophrenia. Biological Psychiatry, 50, 71\u201383.","journal-title":"Biological Psychiatry"},{"key":"454074_CR14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1176\/appi.ajp.158.3.497","volume":"158","author":"R.A. Chambers","year":"2001","unstructured":"Chambers, R.A. & Potenza, M.N. (2001). Schizophrenia and pathological gambling. American Journal of Psychiatry, 158, 497\u2013498. [Letter].","journal-title":"American Journal of Psychiatry"},{"key":"454074_CR15","unstructured":"Chambers, R.A. & Potenza, M.N. (in press). Impulse control disorders. In M.J. Adinoff & R.B. Daroff (Eds.), The encyclopedia of neurological sciences. San Diego, California: Academic Press."},{"key":"454074_CR16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/070674379804300104","volume":"43","author":"D.N. Crockford","year":"1998","unstructured":"Crockford, D.N. & el-Guebaly, N. (1998). Naltrexone in the treatment of pathological gambling and alcohol dependence. Canadian Journal of Psychiatry, 43, 86. [Letter].","journal-title":"Canadian Journal of Psychiatry"},{"key":"454074_CR17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/scnp.2001.22919","volume":"6","author":"R.M. Cunningham-Williams","year":"2001","unstructured":"Cunningham-Williams, R.M. & Cottler, L.B. (2001). The epidemiology of pathological gambling. Seminars in Clinical Neuropsychiatry, 6:155\u2013166.","journal-title":"Seminars in Clinical Neuropsychiatry"},{"key":"454074_CR18","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2105\/AJPH.88.7.1093","volume":"88","author":"R.M. Cunningham-Williams","year":"1998","unstructured":"Cunningham-Williams, R.M., Cottler, L.B., Compton, W.M. 3rd, & Spitznagel, E.L. (1998). Taking chances: problem gamblers and mental health disorders\u2014results from the St. Louis Epidemiologic Catchment Area Study. American Journal of Public Health. 88:1093\u20131096.","journal-title":"American Journal of Public Health"},{"key":"454074_CR19","first-page":"395","volume":"44","author":"K.A. Daly","year":"1999","unstructured":"Daly, K.A. & Fatemi, S.H. (1999). Lamotrogine and impulse behavior. Canadian Journal of Psychiatry, 44, 395-396. [Letter].","journal-title":"Canadian Journal of Psychiatry"},{"key":"454074_CR20","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1530-0277.1996.tb01679.x","volume":"20","author":"D. Davidson","year":"1996","unstructured":"Davidson, D., Swift, R.M., & Fitz, E. (1996). Naltrexone increases the latency to drink in social drinkers. Alcoholism and Clinical Experimental Research, 20, 732\u2013739.","journal-title":"Alcoholism and Clinical Experimental Research"},{"key":"454074_CR21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1017\/S1092852900006003","volume":"3","author":"C.M. DeCaria","year":"1998","unstructured":"DeCaria, C.M., Begaz, T., & Hollander, E. (1998). Serotonergic and noradrenergic function in pathological gambling. CNS Spectrums, 3, 38\u201347.","journal-title":"CNS Spectrums"},{"issue":"S8","key":"454074_CR22","first-page":"80","volume":"57","author":"C.M. DeCaria","year":"1996","unstructured":"DeCaria, C.M., Hollander, E., Grossman, R., Wong, C.M., Mosovich, S.A., & Cherkasky, S. (1996). Diagnosis, neurobiology, and treatment of pathological gambling. Journal of Clinical Psychiatry, 57(S8), 80\u201383.","journal-title":"Journal of Clinical Psychiatry"},{"key":"454074_CR23","unstructured":"De la Gandara, J.J. (1999). Fluoxetine: open-trial in pathological gambling. Presented at the 152nd Annual Meeting of the American Psychiatric Association; May 16\u201321; Washington, DC. [Abstract]."},{"key":"454074_CR24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1017\/S1092852900012839","volume":"5","author":"C.K. Farren","year":"2000","unstructured":"Farren, C.K., Rezvani, A.H., Overstreet, D., & O'Malley, S. (2000). Combination pharmacotherapy in alcoholism: a novel treatment approach. CNS Spectrums, 5, 70\u201376.","journal-title":"CNS Spectrums"},{"key":"454074_CR25","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/00004583-199706000-00007","volume":"36","author":"D.J. Feeney","year":"1997","unstructured":"Feeney, D.J. & Klykylo, W.M. (1997). Treatment for kleptomania. Journal of the American Academy of Child & Adolescent Psychiatry, 36, 723\u2013724.","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"key":"454074_CR26","first-page":"1592","volume":"21","author":"L.R. Gardell","year":"1997","unstructured":"Gardell, L.R., Reid, L.D., Boedeker, K.L., Liakos, T.M., & Hubbell, C.L. (1997a). Isradipine and naltrexone in combination with isradipine interact with a period of abstinence to reduce rats' intakes of an alcoholic beverage. Alcoholism and Clinical Experimental Research, 21, 1592\u20131598.","journal-title":"Alcoholism and Clinical Experimental Research"},{"key":"454074_CR27","first-page":"1435","volume":"21","author":"L.R. Gardell","year":"1997","unstructured":"Gardell, L.R., Whalen, C.A., Chattophadyay, S., Cavallaro, C.A., Hubbell, C.L., & Reid, L.D. (1997b). Combination of naltrexone and fluoxetine on rats' propensity to take alcoholic beverage. Alcoholism and Clinical Experimental Research, 21, 1435\u20131439.","journal-title":"Alcoholism and Clinical Experimental Research"},{"key":"454074_CR28","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00001504-200005000-00015","volume":"13","author":"T.P. George","year":"2000","unstructured":"George, T.P. & Krystal, J.H. (2000). Comorbidity of psychiatric and substance abuse disorders. Current Opinion in Psychiatry, 13, 327\u2013331.","journal-title":"Current Opinion in Psychiatry"},{"key":"454074_CR29","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1176\/appi.ajp.157.11.1835","volume":"157","author":"T.P. George","year":"2000","unstructured":"George, T.P., Ziedonis, D.M., Feingold, A., Pepper, W.T., Satterburg, C.A., Winkel, J., Rounsaville, B. J., & Kosten, T.R. (2000). Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. American Journal of Psychiatry, 157, 1835\u20131842.","journal-title":"American Journal of Psychiatry"},{"key":"454074_CR30","unstructured":"Gerstein, D., Hoffmann, J., Larison, C., Engelman, L., Murphy, S., Palmer, A., Chuchro, L., Toce, M., Johnson, R., Buie, T., & Hill, M.A. (1999). Gambling impact and behavior study. National Opinion Research Center, University of Chicago. http:\/\/www.norc.uchicago.edu\/new\/gambfin.htm\"."},{"key":"454074_CR31","first-page":"36","volume":"51","author":"W.K. Goodman","year":"1990","unstructured":"Goodman, W.K., McDougle, C.J., Price, L.H., Riddle, M.A., Pauls, D.L., & Leckman, J.F. (1990). Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive-compulsive disorder? Journal of Clinical Psychiatry, 51, 36\u201343.","journal-title":"Journal of Clinical Psychiatry"},{"key":"454074_CR32","volume-title":"Manic-depressive illness","author":"F.K. Goodwin","year":"1990","unstructured":"Goodwin, F.K. & Jamison, K.R. (1990). Manic-depressive illness. New York City, NY: Oxford University Press."},{"key":"454074_CR33","doi-asserted-by":"crossref","first-page":"957","DOI":"10.4088\/JCP.v62n1207","volume":"62","author":"J.E. Grant","year":"2001","unstructured":"Grant, J.E. & Kim, S.W. (2001a). Demographic and clinical features of 131 adult pathological gamblers. Journal of Clinical Psychiatry, 62, 957\u2013962.","journal-title":"Journal of Clinical Psychiatry"},{"key":"454074_CR34","first-page":"161","volume":"32","author":"J.E. Grant","year":"2001","unstructured":"Grant, J.E. & Kim, S.W. (2001b). Pharmacotherapy of pathological gambling disorder. Psychiatric Annals, 32, 161\u2013170.","journal-title":"Psychiatric Annals"},{"key":"454074_CR35","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4088\/JCP.v63n0413","volume":"63","author":"J.E. Grant","year":"2002","unstructured":"Grant, J.E. & Kim, S.W. (2002). An open label study of naltrexone in the treatment of kleptomania. Journal of Clinical Psychiatry, 63, 349\u2013356.","journal-title":"Journal of Clinical Psychiatry"},{"key":"454074_CR36","first-page":"218","volume-title":"ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education and Welfare publication (ADM) 76\u2013338","author":"W. Guy","year":"1976","unstructured":"Guy, W. (1976). ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education and Welfare publication (ADM) 76\u2013338. Rockville, MD: National Institute of Mental Health, 218\u2013222."},{"key":"454074_CR37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-2007-1014292","volume":"27","author":"R. Haller","year":"1994","unstructured":"Haller, R. & Hinterhuber, H. (1994). Treatment of pathological gambling with carbamazepine. Pharmacopsychiatry, 27, 129.","journal-title":"Pharmacopsychiatry"},{"key":"454074_CR38","unstructured":"Head, C.A., Vessichio, J.C., Sahady, D.M., Kosten, T.R., & George, T. P. (2000). Buproprion versus placebo for smoking cessation in schizophrenia: effects of atypical antipsychotic drugs. Presented at the 7\n\n                    th\n                  \nAnnual Meeting of the Society for Research of Nicotine and Tobacco. [Abstract]."},{"key":"454074_CR39","unstructured":"Hollander, E. (2001). \u201cVery bad behaviors\u201d in the Symposium \u201cThe impulsive aggressive spectrum: Challenging populations.\u201d Presented at the 154th Annual Meeting of the American Psychiatric Association; May 7 and 8; New Orleans, LA. [Abstract]."},{"key":"454074_CR40","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0006-3223(00)00241-9","volume":"47","author":"E. Hollander","year":"2000","unstructured":"Hollander, E., DeCaria, C.M., Finkell, J.N., Begaz, T., Wong, C.M., & Cartwright, C. (2000). A randomized double-blind fluvoxamine\/placebo crossover trial in pathological gambling. Biological Psychiatry, 47, 813\u2013817.","journal-title":"Biological Psychiatry"},{"key":"454074_CR41","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1176\/ajp.155.12.1781","volume":"155","author":"E. Hollander","year":"1998","unstructured":"Hollander, E., DeCaria, C.M., Mari, E., Wong, C.M., Mosovich, S., Grossman, R., & Begaz, T. (1998). Short-term single-blind fluvoxamine treatment of pathological gambling. American Journal of Psychiatry, 155, 1781\u20131783.","journal-title":"American Journal of Psychiatry"},{"key":"454074_CR42","first-page":"710","volume":"149","author":"E. Hollander","year":"1992","unstructured":"Hollander, E., Frenkel, M., DeCaria, C., Trungold, S., & Stein, D.J. (1992). Treatment of pathological gambling with clomipramine. American Journal of Psychiatry, 149, 710\u2013711. [Letter].","journal-title":"American Journal of Psychiatry"},{"issue":"S4","key":"454074_CR43","first-page":"3","volume":"56","author":"E. Hollander","year":"1995","unstructured":"Hollander, E. & Wong, C.M. (1995). Obsessive-compulsive spectrum disorders. Journal of Clinical Psychiatry, 56(S4), 3\u20136.","journal-title":"Journal of Clinical Psychiatry"},{"key":"454074_CR44","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0376-8716(77)90027-8","volume":"2","author":"L. Hollister","year":"1977","unstructured":"Hollister, L., Schwin, R.L., & Kasper, P. (1977). Naltrexone treatment of opiate-dependent persons. Drug and Alcohol Dependence, 2, 203\u2013209.","journal-title":"Drug and Alcohol Dependence"},{"key":"454074_CR45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2466\/pr0.1998.83.1.3","volume":"83","author":"E.K. Holmes","year":"1998","unstructured":"Holmes, E.K., Mateczun, J.M., Lall, R., Wilcove, G.L. (1998). Pilot study of suicide risk factors among personnel in the United States Marine Corps (Pacific Forces). Psychological Reports, 83, 3\u201311.","journal-title":"Psychological Reports"},{"key":"454074_CR46","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1037\/0022-006X.64.5.1044","volume":"64","author":"A.J. Jaffe","year":"1996","unstructured":"Jaffe, A.J., Rounsaville, B., Chang, G., Shottenfeld, R.S., Meyer, R.E., & O'Malley, S.S. (1996). Naltrexone, relapse prevention and supportive therapy with alcoholics: an analysis of patient matching. Journal of Consulting Clinical Psychology, 64, 1044\u20131053.","journal-title":"Journal of Consulting Clinical Psychology"},{"key":"454074_CR47","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","volume":"45","author":"J. Kane","year":"1988","unstructured":"Kane, J., Honigfeld, G., Singer, J, & Meltzer, H. (1988). Clozapine for the treatment-resistant schizophrenic: a double blind comparison with chlorpromazine. Archives of General Psychiatry, 45, 789\u2013796.","journal-title":"Archives of General Psychiatry"},{"key":"454074_CR48","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/sj.mp.4000327","volume":"3","author":"S. Kapur","year":"1998","unstructured":"Kapur, S. (1998). A new framework for investigating antipsychotic action in humans: lessons from PET imaging. Molecular Psychiatry, 3, 135\u2013140.","journal-title":"Molecular Psychiatry"},{"key":"454074_CR49","first-page":"159","volume":"59","author":"S.W. Kim","year":"1998","unstructured":"Kim, S.W. (1998). Opioid antagonists in the treatment of impulse control disorders. Journal of Clinical Psychiatry, 59, 159\u2013164.","journal-title":"Journal of Clinical Psychiatry"},{"key":"454074_CR50","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00004850-200109000-00006","volume":"16","author":"S.W. Kim","year":"2001","unstructured":"Kim, S.W. & Grant, J.E. (2001a). An open naltrexone treatment study of pathological gambling disorder. International Clinical Psychopharmacology, 16, 285\u2013289.","journal-title":"International Clinical Psychopharmacology"},{"key":"454074_CR51","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1053\/scnp.2001.22924","volume":"6","author":"S.W. Kim","year":"2001","unstructured":"Kim, S.W. & Grant, J.E. (2001b). The psychopharmacology of pathological gambling. Seminars in Clinical Neuropsychiatry, 6, 184\u2013194.","journal-title":"Seminars in Clinical Neuropsychiatry"},{"key":"454074_CR52","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0165-1781(01)00327-4","volume":"104","author":"S.W. Kim","year":"2001","unstructured":"Kim, S.W. & Grant, J.E. (2001c). Personality dimensions in pathological gambling disorder and obsessive compulsive disorder. Psychiatry Research, 104, 205\u2013212.","journal-title":"Psychiatry Research"},{"key":"454074_CR53","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/00004714-200112000-00024","volume":"21","author":"S.W. Kim","year":"2001","unstructured":"Kim, S.W., Grant, J.E., Adson, D.E., & Remmel, R.P. (2001a). A preliminary report on a possible naltrexone and nonsteroidal analgesics interaction. Journal of Clinical Psychopharmacology, 21, 632\u2013634. [Letter].","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"454074_CR54","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0006-3223(01)01079-4","volume":"49","author":"S.W. Kim","year":"2001","unstructured":"Kim, S.W., Grant, J.E., Adson, D.E., & Shin, Y.C. (2001b). Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biological Psychiatry, 49, 914\u2013921.","journal-title":"Biological Psychiatry"},{"key":"454074_CR55","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4088\/JCP.v63n0606","volume":"63","author":"S.W. Kim","year":"2002","unstructured":"Kim, S.W., Grant, J.E., Adson, D.E., Shin, Y.C., & Zaninelli, R.M. (2002). A double-blind, placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. Journal of Clinical Psychiatry, 63, 501\u2013507.","journal-title":"Journal of Clinical Psychiatry"},{"key":"454074_CR56","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1177\/01454455940182006","volume":"18","author":"R. Ladouceur","year":"1994","unstructured":"Ladouceur, R., Boisvert, J.M., & Dumont, J. (1994). Cognitive-behavioral treatment for adolescent pathological gamblers. Behavior Modification, 18, 230\u2013242.","journal-title":"Behavior Modification"},{"key":"454074_CR57","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF01019763","volume":"7","author":"H.R. Lesieur","year":"1991","unstructured":"Lesieur, H.R. & Rosenthal, R.J. (1991). Pathological gambling: a review of the literature (prepared for the American Psychiatric Association Task Force of DSM-IV Committee on Disorders of Impulse Control Not Elsewhere Classified). Journal of Gambling Studies, 7, 5\u201339.","journal-title":"Journal of Gambling Studies"},{"key":"454074_CR58","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1017\/S1092852900012827","volume":"5","author":"B.J. Mason","year":"2000","unstructured":"Mason, B.J. & Ownby, R.L. (2000). Acamprosate for the treatment of alcohol dependence: a review of double-blind, placebo-controlled trials. CNS Spectrums, 5, 58\u201369.","journal-title":"CNS Spectrums"},{"key":"454074_CR59","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00004583-199804000-00009","volume":"37","author":"A. Martin","year":"1998","unstructured":"Martin, A., Scahill, L., Vitulano, L., & King, R.A. (1998). Stimulant use and trichotillomania. Journal of the American Academy of Child & Adolescent Psychiatry, 37, 349\u201350.","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"key":"454074_CR60","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0306-4522(84)90048-4","volume":"11","author":"R.T. Matthews","year":"1984","unstructured":"Matthews, R.T. & German, D.C. (1984). Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine. Neuroscience, 11, 617\u2013625.","journal-title":"Neuroscience"},{"key":"454074_CR61","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1001\/archpsyc.57.8.794","volume":"57","author":"C.J. McDougle","year":"2000","unstructured":"McDougle, C.J., Epperson, C.N., Pelton, G.H., Wasylink, S., & Price, L.H. (2000). A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Archives of General Psychiatry, 57, 794\u2013801.","journal-title":"Archives of General Psychiatry"},{"key":"454074_CR62","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1001\/archpsyc.1994.03950040046006","volume":"51","author":"C.J. McDougle","year":"1994","unstructured":"McDougle, C.J., Goodman, W.K., Leckman, J.F., Lee, N.C., Heninger, G.R., & Price, L.H. (1994). Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder: a double-blind, placebo-controlled study in patients with and without tics. Archives of General Psychiatry, 51, 302\u2013308.","journal-title":"Archives of General Psychiatry"},{"key":"454074_CR63","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/depr.3050010302","volume":"1","author":"S.L. McElroy","year":"1993","unstructured":"McElroy, S.L., Hudson, J.I., Phillips, K.A., Keck, P.E., & Pope, H.G. (1993). Clinical and theoretical implications of a possible link between obsessive-compulsive and impulse control disorders. Depression, 1, 121\u2013132.","journal-title":"Depression"},{"key":"454074_CR64","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0010-440X(96)90001-2","volume":"37","author":"S.L. McElroy","year":"1996","unstructured":"McElroy, S.L., Pope, H.G. Jr., Keck, P.E., Hudson, J.I., Phillips, K.A., & Strakowski, S.M. (1996). Are impulse-control disorders related to bipolar disorder? Comprehensive Psychiatry, 37, 229\u2013240.","journal-title":"Comprehensive Psychiatry"},{"key":"454074_CR65","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1001\/jama.1993.03500150065028","volume":"269","author":"A.T. McLellan","year":"1993","unstructured":"McLellan, A.T., Arndt, I.O., Metzger, D.S., Woody, G.E., & O'Brien, C.P. (1993). The effects of psychosocial services in substance abuse treatment. Journal of the American Medical Association, 269, 1953\u20131959.","journal-title":"Journal of the American Medical Association"},{"key":"454074_CR66","volume-title":"Neuropsychopharmacology: the fourth generation of progress","author":"H. Y. Meltzer","year":"1995","unstructured":"Meltzer, H. Y. (1995). Atypical antipsychotic drugs. In F.E. Bloom & D.J. Kupfer (Eds), Neuropsychopharmacology: the fourth generation of progress. New York: D.J. Raven Press."},{"key":"454074_CR67","doi-asserted-by":"crossref","first-page":"106S","DOI":"10.1038\/sj.npp.1395370","volume":"21","author":"H. Y. Meltzer","year":"1999","unstructured":"Meltzer, H. Y. (1999). The role of serotonin in antipsychotic drug action. Neuropsychopharmacology, 21, 106S\u2013115S.","journal-title":"Neuropsychopharmacology"},{"key":"454074_CR68","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0006-3223(87)90127-2","volume":"22","author":"J.E. Mitchell","year":"1987","unstructured":"Mitchell, J.E., Morley, J.E., Levine, A.S., Hatsukami, D., Gannon, M., & Pfohl, D. (1987). High-dose naltrexone therapy and dietary counseling for obesity. Biological Psychiatry, 22, 35\u201342.","journal-title":"Biological Psychiatry"},{"key":"454074_CR69","first-page":"1386","volume":"23","author":"P.M Monti","year":"1999","unstructured":"Monti, P.M, Rohsenow, D.J., Hutchison, K., Swift, R.M., Mueller, T.I., Colby, S.M., Brown, R.A., Gulliver, S.B., Gordon, A., & Abrams, D.B. (1999). Naltrexone's effect on cue-elicited craving among alcoholics in treatment. Alcoholism and Clinical Experimental Research, 23, 1386\u20131394.","journal-title":"Alcoholism and Clinical Experimental Research"},{"key":"454074_CR70","first-page":"92A","volume":"20","author":"P.M Monti","year":"1996","unstructured":"Monti, P.M, Rohsenow, D.J., Swift, R.M., Abrams, D.B., Colby, S.M., & Mueller, T.I. (1996). Effect of naltrexone on urge to drink during alcohol cue exposure: preliminary results. Alcoholism and Clinical Experimental Research, 20, 92A.","journal-title":"Alcoholism and Clinical Experimental Research"},{"key":"454074_CR71","first-page":"785","volume":"80","author":"J.A. Moskowitz","year":"1980","unstructured":"Moskowitz, J.A. (1980). Lithium and lady luck: use of lithium carbonate in compulsive gambling. New York State Journal of Medicine, 80, 785\u2013788.","journal-title":"New York State Journal of Medicine"},{"key":"454074_CR72","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1017\/S1092852900006799","volume":"4","author":"C. Nordin","year":"1999","unstructured":"Nordin, C. & Eklundh, T. (1999). Altered CSF 5-HIAA disposition in pathologic male gamblers. CNS Spectrums, 4, 25\u201333.","journal-title":"CNS Spectrums"},{"key":"454074_CR73","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.278.5335.66","volume":"278","author":"C.P. O'Brien","year":"1997","unstructured":"O'Brien, C.P. (1997). A range of research-based pharmacotherapies for addiction. Science, 278, 66\u201370.","journal-title":"Science"},{"key":"454074_CR74","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archpsyc.1992.01820110045007","volume":"49","author":"S.S. O'Malley","year":"1992","unstructured":"O'Malley, S.S., Jaffe, A.J., Chang, G., Schottenfeld, R.S., Meyer, R.E., & Rounsaville, B.J. (1992). Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Archives of General Psychiatry, 49, 881\u2013887.","journal-title":"Archives of General Psychiatry"},{"key":"454074_CR75","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4088\/JCP.v63n0704","volume":"63","author":"S. Pallanti","year":"2002","unstructured":"Pallanti, S., Quercioli, L., Sood, E., & Hollander E. (2002). Lithium and valproate treatment of pathological gambling: a randomized single-blind study. Journal of Clinical Psychiatry, 63, 559\u2013564.","journal-title":"Journal of Clinical Psychiatry"},{"key":"454074_CR76","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1176\/ps.50.8.1021","volume":"50","author":"N.M. Petry","year":"1999","unstructured":"Petry, N.M. & Armentano, C. (1999). Prevalence, assessment, and treatment of pathological gambling: a review. Psychiatric Services, 50, 1021\u20131027.","journal-title":"Psychiatric Services"},{"key":"454074_CR77","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/scnp.2001.22920","volume":"6","author":"N.M. Petry","year":"2001","unstructured":"Petry, N.M. & Roll, J.M. (2001). A behavioral approach to understanding and treating pathological gambling. Seminars in Clinical Neuropsychiatry, 6, 177\u2013183.","journal-title":"Seminars in Clinical Neuropsychiatry"},{"key":"454074_CR78","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/0091-3057(80)90460-8","volume":"12","author":"A.G. Phillips","year":"1980","unstructured":"Phillips, A.G. & LePiane, F.G. (1980). Reinforcing effects of morphine microinjection onto the ventral tegmental area. Pharmacology Biochemistry and Behavior, 12, 965\u2013968.","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"454074_CR79","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1943-278X.1997.tb00516.x","volume":"27","author":"D.P. Phillips","year":"1997","unstructured":"Phillips, D.P., Welty, W.R., & Smith, M.M. (1997). Elevated suicide levels associated with legalized gambling. Suicide and Life Threatening Behavior, 27, 373\u2013378.","journal-title":"Suicide and Life Threatening Behavior"},{"key":"454074_CR80","unstructured":"Physicians' Desk Reference (2001). 55th Ed. Medical Economics Company. Montvale, NJ."},{"key":"454074_CR81","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1053\/scnp.2001.22929","volume":"6","author":"M.N. Potenza","year":"2001","unstructured":"Potenza, M.N. (2001). The neurobiology of pathological gambling. Seminars in Clinical Neuropsychiatry, 6, 217\u2013226.","journal-title":"Seminars in Clinical Neuropsychiatry"},{"key":"454074_CR82","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3928\/0048-5713-20020301-11","volume":"32","author":"M.N. Potenza","year":"2002","unstructured":"Potenza, M.N. (2002). A perspective on future directions in the prevention, treatment and research of pathological gambling. Psychiatric Annals, 32, 203\u2013207.","journal-title":"Psychiatric Annals"},{"key":"454074_CR83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1525-1497.2002.10812.x","volume":"17","author":"M.N. Potenza","year":"2002","unstructured":"Potenza, M.N., Fiellin, D.A., Heninger, G.R., Rounsaville, B.J., & Mazure, C.M. (2002). Gambling: an addictive behavior with primary care implications. Journal of General Internal Medicine, 17, 1\u201312.","journal-title":"Journal of General Internal Medicine"},{"key":"454074_CR84","first-page":"1725","volume-title":"Neuropsychopharmacology: the 5th generation of progress","author":"M.N. Potenza","year":"2002","unstructured":"Potenza, M.N. & Hollander, E. (2002). Pathological gambling and impulse control disorders. In J. Coyle, C. Nemeroff, D. Charney, & K. Davis (Eds), Neuropsychopharmacology: the 5th generation of progress (pp. 1725\u20131741). Baltimore, MD: Lippincott Williams and Wilkens."},{"key":"454074_CR85","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/jama.286.2.141","volume":"286","author":"M.N. Potenza","year":"2001","unstructured":"Potenza, M.N., Kosten, T.R., & Rounsaville, B.J. (2001). Pathological gambling. Journal of the American Medical Association, 286, 141\u2013144.","journal-title":"Journal of the American Medical Association"},{"key":"454074_CR86","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2165\/00023210-199809030-00005","volume":"9","author":"M.N. Potenza","year":"1998","unstructured":"Potenza, M.N. & McDougle, C.J. (1998). Potential of atypical antipsychotics in the treatment of non-psychotic disorders. CNS Drugs, 9, 213\u2013232.","journal-title":"CNS Drugs"},{"key":"454074_CR87","first-page":"389","volume":"28","author":"M.N. Potenza","year":"2000","unstructured":"Potenza, M.N., Steinberg, M.A., McLaughlin, S.D., Wu, R., Rounsaville, B.J., & O'Malley, S.S. (2000). Illegal behaviors in problem gambling: analysis of data from a gambling helpline. Journal of the American Academy of Psychiatry and the Law, 28, 389\u2013403.","journal-title":"Journal of the American Academy of Psychiatry and the Law"},{"key":"454074_CR88","first-page":"233","volume":"57","author":"A.S. Roth","year":"1996","unstructured":"Roth, A.S., Ostroff, R.B., & Hoffman, R.E. (1996). Naltrexone as a treatment for repetitive self-injurious behaviour: an open-label trial. Journal of Clinical Psychiatry, 57, 233\u2013237.","journal-title":"Journal of Clinical Psychiatry"},{"key":"454074_CR89","first-page":"37","volume-title":"Potentiating the effects of medications","author":"B.J. Rounsaville","year":"1995","unstructured":"Rounsaville, B.J. (1995). Can psychotherapy rescue naltrexone treatment of opioid addiction? In L.S. Onken & J.D. Blaine (Eds.), Potentiating the effects of medications. Rockville, Maryland: National Institute on Drug Abuse Research Monograph, 105, 37\u201352."},{"key":"454074_CR90","unstructured":"Rugle, L. (2000). The use of olanzapine in the treatment of video poker pathological gamblers. Presented at the conference entitled, \u201cThe Comorbidity of Pathological Gambling: A Current Research Synthesis\u201d December 3\u20135; Las Vegas, Nevada. [Abstract]."},{"key":"454074_CR91","first-page":"303","volume":"57","author":"S. Saxena","year":"1996","unstructured":"Saxena, S., Wang, D., Bystritsky, A., & Baxter, L.R. (1996). Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder. Journal of Clinical Psychiatry, 57, 303\u2013306.","journal-title":"Journal of Clinical Psychiatry"},{"key":"454074_CR92","first-page":"261","volume":"7","author":"P. Seeman","year":"1992","unstructured":"Seeman, P. (1992). Dopamine receptor sequences: therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychopharmacology, 7, 261\u2013284.","journal-title":"Neuropsychopharmacology"},{"key":"454074_CR93","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF01539174","volume":"12","author":"H.J. Shaffer","year":"1996","unstructured":"Shaffer, H.J. & Hall, M.N. (1996). Estimating the prevalence of adolescent gambling disorders: a quantitative synthesis and guide toward standard gambling nomenclature. Journal of Gambling Studies, 12, 193\u2013214.","journal-title":"Journal of Gambling Studies"},{"key":"454074_CR94","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.2105\/AJPH.89.9.1369","volume":"89","author":"H.J. Shaffer","year":"1999","unstructured":"Shaffer, H.J., Hall, M.N., & Vander Bilt, J. (1999). Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis. American Journal of Public Health, 89, 1369\u20131376.","journal-title":"American Journal of Public Health"},{"key":"454074_CR95","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2114\/jpa.18.37","volume":"18","author":"K. Shinohara","year":"1999","unstructured":"Shinohara, K., Yanagisawa, A., Kagota, Y., Gomi, A., Nemoto, K., Moriya, E., Furusawa, E., Furuya, K., & Tersawa, K. (1999). Physiological changes in Pachinko players; beta-endorphin, catecholamines, immune system substances and heart rate. Applied Human Science, 18, 37\u201342.","journal-title":"Applied Human Science"},{"key":"454074_CR96","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4088\/JCP.v58n0306","volume":"58","author":"D.J. Stein","year":"1997","unstructured":"Stein, D.J., Bouwer, M.B., Hawkridge, S., & Emsley, R.A. (1997). Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders. Journal of Clinical Psychiatry, 58, 119\u2013122.","journal-title":"Journal of Clinical Psychiatry"},{"key":"454074_CR97","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/0091-3057(84)90017-0","volume":"20","author":"J. Stewart","year":"1984","unstructured":"Stewart, J. (1984). Reinstatement of heroin and cocaine self-administration behavior in the rat by intracerebral application of morphine in the ventral tegmental area. Pharmacology Biochemistry and Behavior, 20, 917\u2013923.","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"454074_CR98","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/BF02245813","volume":"120","author":"G. Sutherland","year":"1995","unstructured":"Sutherland, G., Stapleton, J.A., Russell, M.A.H., & Feyerabend, C. (1995). Naltrexone, smoking behaviour and cigarette withdrawal. Psychopharmacology, 120, 418\u2013425.","journal-title":"Psychopharmacology"},{"key":"454074_CR99","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1017\/S1092852900012815","volume":"5","author":"R.M. Swift","year":"2000","unstructured":"Swift, R.M. (2000). Opioid antagonists and alcoholism treatment. CNS Spectrums, 5, 49\u201357.","journal-title":"CNS Spectrums"},{"key":"454074_CR100","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1037\/0022-006X.65.5.727","volume":"65","author":"C. Sylvain","year":"1997","unstructured":"Sylvain, C., Ladouceur, R., & Boisvert, J.M. (1997). Cognitive and behavioral treatment of pathological gambling: a controlled study. Journal of Consulting and Clinical Psychology, 65, 727\u2013732.","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"454074_CR101","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF00499899","volume":"330","author":"L. van Wolfswinkel","year":"1985","unstructured":"van Wolfswinkel, L. & van Ree, J.M. (1985). Effects of morphine and naloxone on thresholds of ventral tegmental electrical self-stimulation. Naunyn-Schmiedebergs Archives of Pharmacology, 330, 84\u201392.","journal-title":"Naunyn-Schmiedebergs Archives of Pharmacology"},{"key":"454074_CR102","first-page":"73","volume":"67","author":"K.G. Verebey","year":"1985","unstructured":"Verebey, K.G. & Mule, S.J. (1985). Naltrexone (Trexan): a review of hepatotoxicity issues. NIDA Research Monograph, 67, 73\u201381.","journal-title":"NIDA Research Monograph"},{"key":"454074_CR103","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/cercor\/10.3.318","volume":"10","author":"N.D. Volkow","year":"2000","unstructured":"Volkow, N.D., & Fowler, J.S. (2000). Addiction, a disease of compulsion and drive: Involvement of the orbitofrontal cortex. Cerebral Cortex, 10, 318\u2013325.","journal-title":"Cerebral Cortex"},{"key":"454074_CR104","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/archpsyc.1992.01820110040006","volume":"49","author":"J.R. Volpicelli","year":"1992","unstructured":"Volpicelli, J.R., Alterman, A.I., Hayashida, M., & O'Brien, C.P. (1992). Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry, 49, 876\u2013880.","journal-title":"Archives of General Psychiatry"},{"key":"454074_CR105","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/archpsyc.1997.01830200071010","volume":"54","author":"J.R. Volpicelli","year":"1997","unstructured":"Volpicelli, J.R., Rhines, K.C., Rhines, J.S., Volpicelli, L.A., Alterman, A.I., & O'Brien, C.P. (1997). Naltrexone and alcohol dependence: role of subject compliance. Arch Gen Psychiatry, 54, 737\u2013742.","journal-title":"Arch Gen Psychiatry"},{"key":"454074_CR106","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF02284716","volume":"20","author":"A.S. Walters","year":"1990","unstructured":"Walters, A.S., Barrett, R.P., Feinstein, C., Mercurio, A., & Hole, W.T. (1990). A case report of naltrexone treatment of self-injury and social withdrawal in autism. Journal of Autism and Developmental Disorders, 20, 169\u2013176.","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"454074_CR107","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4088\/JCP.v63n0109","volume":"63","author":"M. Zimmerman","year":"2002","unstructured":"Zimmerman, M. & Breen, R. (2002). An open-label study of citalopram in the treatment of pathological gambling. Journal of Clinical Psychiatry, 63, 44\u201348.","journal-title":"Journal of Clinical Psychiatry"}],"container-title":["Journal of Gambling Studies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1021227214142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1021227214142\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1021227214142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T11:14:05Z","timestamp":1751368445000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1021227214142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":107,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["454074"],"URL":"https:\/\/doi.org\/10.1023\/a:1021227214142","relation":{},"ISSN":["1050-5350","1573-3602"],"issn-type":[{"value":"1050-5350","type":"print"},{"value":"1573-3602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3]]}}}